Efficacy, Safety and Tolerability of the Once-Daily 10 Cm² Rivastigmine Patch Formulation in the Patients With Dementia (with Probable Alzheimer’s Disease). Bangla. J. Neuroscience 2013, 29 (1), 5-14. https://doi.org/10.3329/bjn.v29i1.56165.